Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Elmar A. Joura, Sepp Leodolter, Mauricio Hernandez-Avila, Cosette M. Wheeler, Gonzalo Perez, Laura A. Koutsky, Suzanne M. Garland, Diane M. Harper, Grace WK Tang, Daron G. Ferris, Marc Steben, Ronald W. Jones, Janine Bryan, Frank J. Taddeo, Oliver M. Bautista, Mark T. Esser, Heather L. Sings, Micki Nelson, John W. Boslego, Carlos SattlerEliav Barr, Jorma Paavonen

Research output: Contribution to journal › Article › peer-review

506 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences